Ali Ezzati

Dr. Ali Ezzati is an Associate Professor in the Department of Neurology at the University of California, Irvine (UCI) School of Medicine. His academic career focuses on the intersection of neurology, neuroimaging, and computational approaches to understanding neurological disorders, particularly those involving pain processing, cognitive decline, and neurodegenerative diseases.

Dr. Ezzati's research interests span multiple domains within neurology, with particular emphasis on chronic pain mechanisms, hippocampal structure and function, migraine disorders, and Alzheimer's disease. His work frequently employs advanced neuroimaging techniques, particularly MRI, to investigate structural and functional brain changes associated with various neurological conditions. He has made significant contributions to understanding sex differences in pain processing and hippocampal volume changes, as evidenced by his work on chronic pain in older adults. His research program increasingly integrates machine learning methodologies to develop predictive models for cognitive decline and disease progression.

Analysis of Dr. Ezzati's recent publications reveals a strong trend toward translational research with clinical applications. His work spans from basic neuroscience investigations of hippocampal subfields to large-scale clinical studies examining headache disorders, migraine disability, and Alzheimer's disease biomarkers. A notable pattern is his growing focus on digital health approaches, machine learning applications in neurology, and the development of predictive risk scores for neurological conditions. His research frequently appears in high-impact journals and often involves large multicenter collaborations.

Dr. Ezzati's work has been supported by multiple NIH grants, including those from the National Institute on Aging (NIA) and the National Institute of Mental Health (NIMH), as indicated by the funding sources associated with his publications. His research frequently involves collaborations with major Alzheimer's disease research initiatives including the A4 study and the Alzheimer's Disease Neuroimaging Initiative (ADNI).